BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20499388)

  • 1. Introduction to special section: drug safety in the rheumatic diseases.
    Lovell D
    Arthritis Care Res (Hoboken); 2010 Jun; 62(6):747-8. PubMed ID: 20499388
    [No Abstract]   [Full Text] [Related]  

  • 2. Observations from the OMERACT Drug Safety Summit, May 2008.
    Simon LS; Strand CV; Boers M; Brooks PM; Henry D; Tugwell PS
    J Rheumatol; 2009 Sep; 36(9):2110-3. PubMed ID: 19738222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safe and well tolerated.
    Fleischmann R; Goodson N; Elewaut D
    Rheumatology (Oxford); 2011 Nov; 50(11):1942-3. PubMed ID: 21994400
    [No Abstract]   [Full Text] [Related]  

  • 4. Factors associated with chloroquine-induced retinopathy in rheumatic diseases: comments on the article by Araiza-Casillas et al.
    Easterbrook M
    Lupus; 2004; 13(8):621. PubMed ID: 15462495
    [No Abstract]   [Full Text] [Related]  

  • 5. The possible clinical application of pharmacogenetics in rheumatology.
    Ferraccioli G
    J Rheumatol; 2003 Dec; 30(12):2517-20. PubMed ID: 14719186
    [No Abstract]   [Full Text] [Related]  

  • 6. Introduction to special section: biologic agents in the treatment of rheumatic diseases-the first decade.
    Yelin E; Katz P
    Arthritis Rheum; 2009 May; 61(5):559. PubMed ID: 19405010
    [No Abstract]   [Full Text] [Related]  

  • 7. Ophthalmological monitoring for hydroxychloroquine toxicity: a scientific review of available data.
    Silman A; Shipley M
    Br J Rheumatol; 1997 May; 36(5):599-601. PubMed ID: 9189064
    [No Abstract]   [Full Text] [Related]  

  • 8. Rheumatic Disease Clinics of North America. Drug safety: managing innovation in rheumatology. Foreword.
    Weisman MH
    Rheum Dis Clin North Am; 2012 Nov; 38(4):ix-x. PubMed ID: 23137584
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fetal safety profile of drugs used in the treatment of inflammatory rheumatic diseases].
    Falcão S; Mourão AF; Pimentão JB; Branco JC
    Acta Reumatol Port; 2007; 32(4):323-31. PubMed ID: 18159198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy and rheumatic diseases.
    Malviya AN
    J Assoc Physicians India; 1994 Feb; 42(2):178. PubMed ID: 7860501
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug therapy in adolescents with rheumatic diseases.
    Schaller JG
    Rev Rhum Engl Ed; 1997 Oct; 64(10 Suppl):194S-195S. PubMed ID: 9385680
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rheumatic collagen diseases and drug-induced kidney disorders].
    Yamada A
    Nihon Rinsho Meneki Gakkai Kaishi; 2002 Jun; 25(3):255-62. PubMed ID: 16646161
    [No Abstract]   [Full Text] [Related]  

  • 13. Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: a data-driven review.
    Monach PA; Arnold LM; Merkel PA
    Arthritis Rheum; 2010 Jan; 62(1):9-21. PubMed ID: 20039416
    [No Abstract]   [Full Text] [Related]  

  • 14. Disease-modifying antirheumatic drugs.
    Belavic J
    Nursing; 2010 Nov; 40(11):20. PubMed ID: 20975424
    [No Abstract]   [Full Text] [Related]  

  • 15. Guidelines for use of antirheumatic drugs.
    Russell AS; Darmawan J; Scott DL; Brooks PM; Hubscher O
    J Rheumatol Suppl; 1994 Sep; 41():79-81. PubMed ID: 7799391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of methotrexate in childhood rheumatic diseases.
    Wallace CA
    Arthritis Rheum; 1998 Mar; 41(3):381-91. PubMed ID: 9506564
    [No Abstract]   [Full Text] [Related]  

  • 17. Was risk properly assessed in Carter, et al's safety assessment of tumor necrosis factor antagonists during pregnancy?
    Winger EE; Reed JL
    J Rheumatol; 2009 Sep; 36(9):2122; author reply 2123. PubMed ID: 19738224
    [No Abstract]   [Full Text] [Related]  

  • 18. Biologic agents in the treatment of rheumatic diseases with chronic viral infection. Where are we?
    Wendling D; Di Martino V; Herbein G
    J Rheumatol; 2009 Jun; 36(6):1107-8. PubMed ID: 19509089
    [No Abstract]   [Full Text] [Related]  

  • 19. Ocular toxicity of hydroxychloroquine.
    Tehrani R; Ostrowski RA; Hariman R; Jay WM
    Semin Ophthalmol; 2008; 23(3):201-9. PubMed ID: 18432546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Individual and interdisciplinary treatment of rheumatic diseases in pregnancy].
    Bolz M
    Dtsch Med Wochenschr; 2008 Nov; 133(46):2415. PubMed ID: 18988135
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.